🔎 Trials Near Me

Akèy › Kansè poumon › Colorado

Etid klinik pou Kansè poumon nan Colorado

38 etid pou Kansè poumon ap chèche patisipan nan sit nan Colorado.

Vil nan Colorado

Tèks ofisyèl etid la (Anglè)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Rocky Mountain Cancer Centers-Aurora, Aurora
  • UCHealth University of Colorado Hospital, Aurora
  • Rocky Mountain Cancer Centers-Boulder, Boulder
  • ak 13 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Rocky Mountain Cancer Center, Denver
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Rocky Mountain Regional VA Medical Center, Aurora
  • UCHealth University of Colorado Hospital, Aurora
  • Penrose-Saint Francis Healthcare, Colorado Springs
  • ak 15 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Rocky Mountain Cancer Centers-Aurora, Aurora
  • Rocky Mountain Cancer Centers-Boulder, Boulder
  • Kaiser Permanente-Franklin, Denver
  • ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Kaiser Permanente-Franklin, Denver
  • Saint Mary's Hospital and Regional Medical Center, Grand Junction
  • Kaiser Permanente-Rock Creek, Lafayette
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Rocky Mountain Cancer Centers, Boulder
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06765109

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

  • Presbyterian/St Lukes Medical Center, Denver
  • Sarah Cannon Research Institute at HealthONE, Denver
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07519655

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Intermountain Health Cancer Center Lutheran Hospital, Golden
  • Cancer Centers of Colorado St. Mary's Regional Hospital, Grand Junction
  • Intermountain Health St. Mary's Regional Hospital, Grand Junction
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06758401

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • Vail Health, Vail
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06712316

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • University of Colorado Cancer Center, Aurora
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • University of Colorado - Aurora Cancer Center, Aurora
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  • UC Health Oncology Research, Colorado Springs
  • Poudre Valley Health Care, Inc. d/b/a Poudre Valley Health System, Fort Collins
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • USO - Rocky Mountain Cancer Centers, Lone Tree
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

  • University of Colorado Health Hospital, Aurora
  • Sarah Cannon Research Institute at HealthOne, Denver
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06561685

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  • Avenzo Therapeutics Recruiting Site, Denver
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07038343

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

  • University of Colorado Cancer Center, Aurora
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06343402

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Keefe Memorial Hospital, Cheyenne Wells
  • Kaiser Permanente-Franklin, Denver
  • Poudre Valley Hospital, Fort Collins
  • ak 5 plis
Ap rekriteVolontè an sante akeyi
Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Sarah Cannon Research Institute - Denver DDU, Denver
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06582017

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

  • University of Colorado Hospital, Aurora
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07499674

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • UCHealth University of Colorado Hospital, Aurora
  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs
  • UCHealth Memorial Hospital Central, Colorado Springs
  • ak 8 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05624996

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

  • Sarah Cannon Research Institute at HealthONE, Denver
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT05652686

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • Colorado Health Medical Group - Medical Oncology & Hematology, Colorado Springs
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT06162221

Integrated Cancer Repository for Cancer Research

  • Advent Health, Greenwood Village
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

  • Sarah Cannon, SCRI Oncology Partners - Health One, Denver
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT04678648

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • UCHealth University of Colorado Hospital, Aurora
  • UCHealth Memorial Hospital Central, Colorado Springs
  • Memorial Hospital North, Colorado Springs
  • ak 5 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT05642572

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

  • Sarah Cannon Research Institute Denver, Denver
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT06922591

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • UCHealth University of Colorado Hospital, Aurora
  • UCHealth Memorial Hospital Central, Colorado Springs
  • Memorial Hospital North, Colorado Springs
  • ak 4 plis
Ap rekriteFaz 2
18 Minutes · Tout sèks · Mizajou May 5, 2026 · NCT06031688

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

  • University of Colorado Cancer Center, Aurora
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 8, 2026 · NCT05987644

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

  • Sarah Cannon Research Institute (SCRI) at HealthONE, Denver
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT05948865

Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer

  • University of Colorado Cancer Center, Aurora
Ap rekriteEtid obsèvasyon
Laj 18 a 85 · Tout sèks · Mizajou Feb 18, 2026 · NCT01580982

Improving Care for Rural Patients With Solid Tumors

  • University of Colorado Hospital, Aurora
  • Memorial Hospital Central, Colorado Springs
  • Memorial Hospital North, Colorado Springs
  • ak 10 plis
Ap rekrite
Laj 18 a 99 · Tout sèks · Mizajou Feb 5, 2026 · NCT04916990

Specimen Banking From Patients With Lung Cancer

  • University of Colorado Cancer Center, Aurora
Ap rekriteEtid obsèvasyon
Laj 18 a 85 · Tout sèks · Mizajou Jan 29, 2026 · NCT01585675

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

  • Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 27, 2026 · NCT05179408

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Aurora
  • Massive Bio SYNERGY-AI site, Denver
  • Massive Bio SYNERGY-AI site, Littleton
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

  • University of Colorado Cancer Center at UC Health Sciences Center, Aurora
Ap rekriteEtid obsèvasyon
Laj 21 a 90 · Tout sèks · Mizajou Sep 22, 2025 · NCT00900419

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.